OriolaCHIX:ORIOLH 38 Buyback Yield % is 0.18 as of Jun. 28, 2026, which is 260% above its 10-year median of 0.05. GuruFocus rates CHIX:ORIOLH with a GF Score™ of 38/100 and a GF Value™ of €1.04 (Fairly Valued). The stock has 5 warning signs investors should review. Among 271 Healthcare Providers & Services companies, Oriola ranks better than 62.36% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Oriola's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Oriola's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oriola Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oriola's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Oriola's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oriola (CHIX:ORIOLH) has a Buyback Yield % of 0.18 as of Jun. 28, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Oriola and its competitors. This is 260% above median its historical median of 0.05. Over the past decade, Oriola's Buyback Yield % has ranged from 0.01 to 0.18. According to the industry distribution chart, Oriola ranks #102 out of 271 companies in the Healthcare Providers & Services industry, placing it in the top 37.6%.
Is Oriola's Buyback Yield % too high?
Oriola's current Buyback Yield % of 0.18 is 260% above median its 10-year median of 0.05. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.18. Based on the distribution chart, Oriola ranks #102 out of 271 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Oriola has a GF Score™ of 38/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Oriola's Buyback Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Oriola ranks #102 out of 271 companies for Buyback Yield %. This puts Oriola in the upper half of its industry. Historically, Oriola's own Buyback Yield % has ranged from 0.01 to 0.18 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Oriola and its competitors. Oriola's current Buyback Yield % is 0.18, which is 260% above median its own 10-year median of 0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oriola stock overvalued right now?
Based on GuruFocus' analysis, Oriola (CHIX:ORIOLH) is currently considered Fairly Valued. The stock's GF Value™ is €1.04, compared to a current price of €0.94 — trading 9.8% below its estimated fair value. The current Buyback Yield % is 0.18, which is 260% above median its 10-year median of 0.05. Oriola's overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Oriola (CHIX:ORIOLH), the current Buyback Yield % is 0.18 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oriola (CHIX:ORIOLH) Overvalued in 2026?
Based on GuruFocus' analysis, Oriola stock appears to be undervalued.
The current stock price of €0.94 is trading 9.8% below its estimated GF Value™ of €1.04.
GuruFocus considers Oriola to be Fairly Valued.
Key valuation signals for CHIX:ORIOLH:
Buyback Yield %: 0.18 (260% above median its 10-year median of 0.05)
GF Value™: €1.04 vs. price of €0.94 (9.8% below fair value)
No single metric tells the full story. See the CHIX:ORIOLH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oriola Corp is a health and wellbeing company operating in Nordic countries. It offers services such as the distribution of pharmaceuticals and other health and well-being products, services, and dose dispensing. Oriola's operations are divided into two segments which include distribution and wholesale. Geographically, the company operates in Sweden, Finland and other countries generating majority revenue from the region of Sweden.
38GF Score
Get the complete analysis for CHIX:ORIOLH
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ORIOLH has been successfully added to your 
